Fifth Third Bancorp
APVO icon

Fifth Third Bancorp’s Aptevo Therapeutics APVO Stock Holding History

Fifth Third Bancorp’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$2 – 2541
2024
Q2 		– Hold
0
– – – 2450
2024
Q1 		– Hold
0
– – – 2358
2023
Q4 		– Hold
0
– – – 2488
2023
Q3 		– Hold
0
– – – 2567
2023
Q2 		– Hold
0
– – – 2562
2023
Q1 		– Hold
0
– – – 2689
2022
Q4 		– Hold
0
– – – 2577
2022
Q3 		– Hold
0
– – – 2508
2022
Q2 		– Hold
0
– – – 2494
2022
Q1 		– Hold
0
– – – 2503
2021
Q4 		– Hold
0
– – – 2530
2021
Q3 		– Hold
0
– – – 2239
2021
Q2 		– Hold
0
– – – 2105
2021
Q1 		– Hold
0
– – – 2029
2020
Q4 		– Hold
0
– – – 1874

Other funds holding APVO

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return